Potential of transcatheter aortic valve replacement to improve post-procedure renal function.
Faillace, Bruno L R; Ribeiro, Henrique B; Campos, Carlos M; Truffa, Adriano A M; Bernardi, Fernando L; Oliveira, Marcos D P; Mariani, José; Marchini, Julio F; Tarasoutchi, Flavio; Lemos, Pedro A.
Cardiovasc Revasc Med
; 18(7): 507-511, 2017 Oct - Nov.
Artigo em Inglês | MEDLINE | ID: mdl-29054156
Percutaneous Balloon Aortic Valvuloplasty and Clinical Outcomes in Severe Aortic Stenosis: Correlation of Procedural Technique and Efficacy.
Biomarkers of Calcific Aortic Valve Disease.
Aortic Valve Bioprostheses: Leaflet Immobility and Valve Thrombosis.
Long-Term Outcomes and Durability of the Mitroflow Aortic Bioprosthesis.
Vascular complications associated with transcatheter aortic valve replacement.
5-year outcomes of transcatheter aortic valve replacement compared with standard treatment for patients with inoperable aortic stenosis (PARTNER 1): a randomised controlled trial.
Mitral annular calcification in patients undergoing aortic valve replacement for aortic valve stenosis.
Impact of pre- and post-procedural anemia on the incidence of acute kidney injury and 1-year mortality in patients undergoing transcatheter aortic valve implantation (from the French Aortic National CoreValve and Edwards 2 [FRANCE 2] Registry).
Transcatheter aortic valve replacement for patients with heart failure.
Insulin resistance and subclinical abnormalities of global and regional left ventricular function in patients with aortic valve sclerosis.